Drawing for REDOXOPHORE

USPTO serial 76354629

REDOXOPHORE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MICHOS, JOHN E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REDOXOPHORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lynn M. Humphreys

JOHN L SLAFSKY WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL RDPALO ALTO, CA 94304-1050UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001chemical additives for use in the manufacture of pharmaceuticals, skin care preparations, and dietary and nutritional supplementsACTIVE—
003Non-medicated skin care preparations, namely creams, lotions, cleansers, moisturizers, astringents, emollients, exfoliators, sunscreens, mousses, toners, masks, powders, foundations, cosmetics, gels, pastes, roll-ons, patches, pads, tissues, wipes, antiperspirants, deodorants, nail polish, hair conditioners, shampoos, scalp treatmentsACTIVE—
005Pharmaceutical preparations for the treatment of inflammatory and ischemic disorders, namely systemic lupus erythematosus, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, autoimmune diabetes, skin inflammation including atopic dermatitis, contact dermatitis, allergic dermatisis, xerosis, eczema, rosacea, seborrhea, psoriasis, thermal and radiation burns, acne, oily skin, wrinkles, excessive cellulite, excessive pore size, intrinsic skin aging, photo aging, photo damage, harmful UV damage, keratinization abnormalities, alopecia, dyspigmentation inflammation due to wounds, scarring or stretch marks, loss of elasticity, skin atrophy, pigmentation control, psoriasis, inhibition of hair growth, inhibition of hair loss, stimulation of hair growth, gingivitis, central nervous system ischemia resulting from cardiac arrest, hypoxemia, transient ischemic attack, stroke or severe hypotension; cerebral ischemia including stroke, ischemic heart disease myocardial ischemia), spinal cord ischemia and paraplegia, retinal ischemia including age-related macular degeneration (ARMD), hepatic ischemia, renal ischemia, dermal ischemia, penile ischemia, pulmonary ischemia, gastric ischemia intestinal ischemia, splenic ischemia, pancreatic ischemia, skeletal muscle ischemia, ischemia associated with diabetic ulcers, gangrenous conditions, post-trauma syndrome, benign prostatic hyperplasia of hypertrophy (BPH), post prostate cancer surgery, cardiac arrest resuscitation, peripheral nerve damage or neuropathise, and dietary and nutritional supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 9, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 9, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 10, 2004CFITCASE FILE IN TICRS—
Jul 12, 2004MAILPAPER RECEIVED—
Jul 12, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 11, 2004EX2GSOU EXTENSION 2 GRANTED—
Mar 11, 2004EXT2SOU EXTENSION 2 FILED—
Mar 11, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2003EX1GSOU EXTENSION 1 GRANTED—
Sep 19, 2003EXT1SOU EXTENSION 1 FILED—
Sep 19, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 1, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 7, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2002NPUBNOTICE OF PUBLICATION—
Oct 30, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 2, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 2, 2002TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Frequently asked questions

Related guidance